Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2002-6-14
pubmed:abstractText
Neointimal hyperplasia is a major cause of restenosis after coronary intervention. Because vascular injury is now recognized to involve an inflammatory response, monocyte chemoattractant protein-1 (MCP-1) might be involved in underlying mechanisms of restenosis. In the present study, we demonstrate the important role of MCP-1 in neointimal hyperplasia after cuff-induced arterial injury. In the first set of experiments, placement of a nonconstricting cuff around the femoral artery of intact mice and monkeys resulted in inflammation in the early stages and subsequent neointimal hyperplasia at the late stages. We transfected with an N-terminal deletion mutant of the human MCP-1 gene into skeletal muscles to block MCP-1 activity in vivo. This mutant MCP-1 works as a dominant-negative inhibitor of MCP-1. This strategy inhibited early vascular inflammation (monocyte infiltration, increased expression of MCP-1, and inflammatory cytokines) and late neointimal hyperplasia. In the second set of experiments, the cuff-induced neointimal hyperplasia was found to be less in CCR2-deficient mice than in control CCR2(+/+) mice. The MCP-1/CCR2 pathway plays a central role in the pathogenesis of neointimal hyperplasia in cuffed femoral artery of mice and monkeys. Therefore, the MCP-1/CCR2 pathway can be a therapeutic target for human restenosis after coronary intervention.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1524-4571
pubmed:author
pubmed:issnType
Electronic
pubmed:day
14
pubmed:volume
90
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1167-72
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12065319-Animals, pubmed-meshheading:12065319-Chemokine CCL2, pubmed-meshheading:12065319-Femoral Artery, pubmed-meshheading:12065319-Gene Expression, pubmed-meshheading:12065319-Genotype, pubmed-meshheading:12065319-Humans, pubmed-meshheading:12065319-Hyperplasia, pubmed-meshheading:12065319-Immunohistochemistry, pubmed-meshheading:12065319-Macaca fascicularis, pubmed-meshheading:12065319-Male, pubmed-meshheading:12065319-Mice, pubmed-meshheading:12065319-Mice, Inbred C57BL, pubmed-meshheading:12065319-Mice, Knockout, pubmed-meshheading:12065319-Plasmids, pubmed-meshheading:12065319-RNA, Messenger, pubmed-meshheading:12065319-Receptors, CCR2, pubmed-meshheading:12065319-Receptors, Chemokine, pubmed-meshheading:12065319-Signal Transduction, pubmed-meshheading:12065319-Time Factors, pubmed-meshheading:12065319-Transfection, pubmed-meshheading:12065319-Tunica Intima
pubmed:year
2002
pubmed:articleTitle
Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys.
pubmed:affiliation
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. egashira@cardiol.med.kyushu-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't